We were delighted to have the opportunity to join TSI at their booth during PDA India Chapter 2024. The central theme of the event revolved around 'Sustaining Quality & Compliance in Pharmaceutical Manufacturing and Regulatory Expectations.'

Key discussions encompassed:

§  Exploring FDA initiatives and their implications for the Indian pharmaceutical landscape.

§  Staying updated on evolving quality standards.

§  Addressing significant gaps within the pharmaceutical industry.

§  Strategies for enhancing Data Integrity.

A highlight of the event was the engaging panel discussions featuring esteemed global leaders. We had the privilege of engaging with prominent figures from the pharmaceutical and biopharmaceutical sectors. They showed keen interest in TSI's systems, particularly those facilitating real-time viable particle counting. Our conversations predominantly revolved around the implementation of BioTrak and product validation processes.